Dacarbazine and alanine aminotransferase increased Patient Reports February 09, 2010

Dacarbazine Side Effects Report #5515904-6
Dacarbazine side effect was reported by a Physician from FRANCE on Nov 13, 2007. Female patient, 73 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, dehydration, gamma-glutamyltransferase increased. Dacarbazine dosage: unknown. During the same period patient was treated with ONDANSETRON, METOCLOPRAMIDE, TRAMADOL, KETOPROFEN, OMEPRAZOLE, INDAPAMIDE, IRBESARTAN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5557417-1
Dacarbazine side effect was reported by a Physician from FRANCE on Dec 06, 2007. Female patient, 73 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood bilirubin increased, dehydration, gamma-glutamyltransferase increased, myalgia, oral intake reduced, rash . Dacarbazine dosage: unknown. During the same period patient was treated with ONDANSETRON, METOCLOPRAMIDE, TRAMADOL, KETOPROFEN, OMEPRAZOLE, INDAPAMIDE, IRBESARTAN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5256952-3
Dacarbazine side effect was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 65 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, chills, headache , pyrexia. Dacarbazine dosage: unknown. During the same period patient was treated with EMEND, NAVOBAN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5604227-2
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on Jan 23, 2008. Female patient, 61 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, pyrexia, vomiting. Dacarbazine dosage: unknown. During the same period patient was treated with RAMIPRIL. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5746736-1
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2008. Male patient, 57 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest x-ray abnormal, dialysis , dyspnoea, glomerular filtration rate decreased, hepatorenal syndrome. Dacarbazine dosage: unknown. During the same period patient was treated with LEXAPRO, PAXENE, NAMENDA, CRESTOR, LISINOPRIL, TRAZODONE, KYTRIL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5765307-4
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2008. Male patient, 57 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dyspnoea, renal failure. Dacarbazine dosage: unknown. During the same period patient was treated with LEXAPRO, PAXENE, NAMENDA, CRESTOR, LISINOPRIL, TRAZODONE, KYTRIL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6140339-5
Dacarbazine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Mar 25, 2009. Male patient, 17 years of age, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, haemoglobin decreased, lymphadenopathy, thymus enlargement. Dacarbazine dosage: 375 MG/M2, 6 CYCLES. During the same period patient was treated with VINBLASTINE SULPHATE, DOXORUBICIN HYDROCHLORIDE. Patient recovered.